Illumina introduced an AI tool designed to assist in diagnosing rare diseases, as part of recent biotech advancements reported on September 4, 2025.

The tool leverages artificial intelligence to analyze genetic data, potentially speeding up rare disease identification.

Benefits

• Improved diagnostic accuracy.
• Support for gene therapy progress.

Mentioned in posts on X.